AVTX logo

Avalo Therapeutics (AVTX) Total Assets

Annual Total Assets

$20.99 M
-$12.37 M-37.08%

December 31, 2023


Summary


Performance

AVTX Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVTXbalance sheetmetrics:

Quarterly Total Assets

$98.45 M
-$9.85 M-9.10%

September 30, 2024


Summary


Performance

AVTX Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVTXbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

AVTX Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-37.1%-9.1%
3 y3 years-52.0%+195.1%
5 y5 years-70.1%+72.1%

AVTX Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-73.8%at low-20.4%+369.0%
5 y5-year-73.8%at low-20.4%+369.0%
alltimeall time-73.8%+313.6%-20.4%+2665.0%

Avalo Therapeutics Total Assets History

DateAnnualQuarterly
Sep 2024
-
$98.45 M(-9.1%)
Jun 2024
-
$108.31 M(-12.5%)
Mar 2024
-
$123.73 M(+489.4%)
Dec 2023
$20.99 M(-37.1%)
$20.99 M(-28.3%)
Sep 2023
-
$29.27 M(+20.8%)
Jun 2023
-
$24.23 M(-33.1%)
Mar 2023
-
$36.23 M(+8.6%)
Dec 2022
$33.37 M(-58.4%)
$33.37 M(-8.7%)
Sep 2022
-
$36.55 M(+13.4%)
Jun 2022
-
$32.22 M(-47.9%)
Mar 2022
-
$61.90 M(-22.8%)
Dec 2021
$80.21 M(+83.3%)
$80.21 M(-15.9%)
Sep 2021
-
$95.36 M(+48.8%)
Jun 2021
-
$64.08 M(+1.2%)
Mar 2021
-
$63.34 M(+44.8%)
Dec 2020
$43.76 M(+21.2%)
$43.76 M(-26.1%)
Sep 2020
-
$59.19 M(-14.5%)
Jun 2020
-
$69.20 M(+56.9%)
Mar 2020
-
$44.12 M(+22.2%)
Dec 2019
$36.11 M
$36.11 M(-36.9%)
DateAnnualQuarterly
Sep 2019
-
$57.19 M(-4.1%)
Jun 2019
-
$59.62 M(-20.4%)
Mar 2019
-
$74.87 M(+6.6%)
Dec 2018
$70.25 M(+64.1%)
$70.25 M(+3.9%)
Sep 2018
-
$67.61 M(+8.8%)
Jun 2018
-
$62.15 M(-4.9%)
Mar 2018
-
$65.36 M(+52.7%)
Dec 2017
$42.81 M(+642.0%)
$42.81 M(+51.8%)
Sep 2017
-
$28.20 M(+366.4%)
Jun 2017
-
$6.05 M(+69.8%)
Mar 2017
-
$3.56 M(-38.3%)
Dec 2016
$5.77 M(-73.4%)
$5.77 M(-39.8%)
Sep 2016
-
$9.58 M(-27.2%)
Jun 2016
-
$13.17 M(-22.2%)
Mar 2016
-
$16.93 M(-21.8%)
Dec 2015
$21.66 M(+75.8%)
$21.66 M(+297.3%)
Sep 2015
-
$5.45 M(-28.1%)
Jun 2015
-
$7.58 M(-17.3%)
Mar 2015
-
$9.17 M(-25.6%)
Dec 2014
$12.32 M(+142.7%)
$12.32 M
Dec 2013
$5.08 M
-

FAQ

  • What is Avalo Therapeutics annual total assets?
  • What is the all time high annual total assets for Avalo Therapeutics?
  • What is Avalo Therapeutics annual total assets year-on-year change?
  • What is Avalo Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Avalo Therapeutics?
  • What is Avalo Therapeutics quarterly total assets year-on-year change?

What is Avalo Therapeutics annual total assets?

The current annual total assets of AVTX is $20.99 M

What is the all time high annual total assets for Avalo Therapeutics?

Avalo Therapeutics all-time high annual total assets is $80.21 M

What is Avalo Therapeutics annual total assets year-on-year change?

Over the past year, AVTX annual total assets has changed by -$12.37 M (-37.08%)

What is Avalo Therapeutics quarterly total assets?

The current quarterly total assets of AVTX is $98.45 M

What is the all time high quarterly total assets for Avalo Therapeutics?

Avalo Therapeutics all-time high quarterly total assets is $123.73 M

What is Avalo Therapeutics quarterly total assets year-on-year change?

Over the past year, AVTX quarterly total assets has changed by -$9.85 M (-9.10%)